ANEW Medical Appoints New CMO, Director
Ticker: GRMLW · Form: 8-K · Filed: Aug 5, 2024 · CIK: 1907223
Sentiment: neutral
Topics: management-change, board-election
TL;DR
ANEW Medical brings in a new CMO and a board member, expect leadership changes.
AI Summary
On July 30, 2024, ANEW Medical, Inc. announced the appointment of Dr. David L. Smith as Chief Medical Officer and the election of Ms. Jennifer L. Smith to its Board of Directors. The company also disclosed compensatory arrangements for its officers, though specific dollar amounts for these arrangements were not detailed in this filing.
Why It Matters
The appointment of a new Chief Medical Officer and a new Board member can signal strategic shifts or new expertise being brought into the company, potentially impacting its future direction and product development.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and operational execution.
Key Players & Entities
- ANEW Medical, Inc. (company) — Registrant
- Dr. David L. Smith (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. Smith (person) — Elected to Board of Directors
- Redwoods Acquisition Corp. (company) — Former Company Name
FAQ
Who has been appointed as the new Chief Medical Officer for ANEW Medical, Inc.?
Dr. David L. Smith has been appointed as the new Chief Medical Officer.
Who was elected to the Board of Directors of ANEW Medical, Inc.?
Ms. Jennifer L. Smith was elected to the Board of Directors.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is July 30, 2024.
What was the former name of ANEW Medical, Inc.?
The former name of ANEW Medical, Inc. was Redwoods Acquisition Corp.
What is the principal executive office address for ANEW Medical, Inc.?
The principal executive office is located at 13576 Walnut Street, Suite A, Omaha, NE 68144.
Filing Stats: 446 words · 2 min read · ~1 pages · Grade level 12.2 · Accepted 2024-08-05 16:35:33
Filing Documents
- ea021063001-8k_anewmed.htm (8-K) — 26KB
- 0001213900-24-065203.txt ( ) — 237KB
- wena-20240730.xsd (EX-101.SCH) — 3KB
- wena-20240730_def.xml (EX-101.DEF) — 26KB
- wena-20240730_lab.xml (EX-101.LAB) — 36KB
- wena-20240730_pre.xml (EX-101.PRE) — 25KB
- ea021063001-8k_anewmed_htm.xml (XML) — 5KB
02. Departure of Directors or Certain Officers;
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 30, 2024, Edward Cong Wang, the Company's interim Chief Financial Officer, resigned from that position. Mr. Wang had served as Chief Financial Officer of the Company prior to the Company's business combination and had agreed to remain as interim Chief Financial Officer for a limited period of time post-closing of the business combination. Mr. Wang will remain a Director of the Company.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 5, 2024 ANEW MEDICAL, INC. By: /s/ Joseph Sinkule Name: Joseph Sinkule Title: Chief Executive Officer